首页> 外文期刊>Journal of Agricultural and Food Chemistry >Lnhibition of cyclophoshamide-induced mutagenicity by microsized powder of selenium-enriched green tea in mice
【24h】

Lnhibition of cyclophoshamide-induced mutagenicity by microsized powder of selenium-enriched green tea in mice

机译:富硒绿茶微粉对小鼠环磷酰胺诱导的致突变性的抑制

获取原文
获取原文并翻译 | 示例
       

摘要

Previously, the antioxidant activity of Se-enriched green tea extracts has been studied in vitro. In the present study, an in vivo micronuclei test was employed to assess the antimutagenic effect of microsized Se-enriched green tea powder (MSTP) in mice bone marrow. Pretreatments of MSTP, micrometer-sized regular tea powder (MRTP), selenite, and MRTP + selenite were given by gavage for 29 consecutive days prior to cyclophoshamide (CP) treatment. Certain key antioxidant enzymes were also investigated to elucidate the mechanism of antimutagenic effect. Results indicated that MSTP and MRTP or selenite alone did not significantly induce micronuclei at either concentration, confirming its nonmutagenicity. In the CP-treated groups, significant suppressions in the micronuclei were recorded following pretreatment with MSTP, MRTP, and selenite administration. The antimutagenic effect of MSTP was evidently observed by significant reduction in the frequencies of micronuclei in bone marrow cells when compared to a positive control group. The administration of MSTP, selenite, and MRTP + selenite also increased the levels of selenium concentration, glutathione peroxidase (GPx), and superoxide dismutase (SOD) enzymes in both blood and liver. However, no pronounced differences in activities of GPx and SOD were found among MSTP, selenite, and MRTP + selenite. The present findings demonstrate that the antimutagenic potential of MSTP could not be solely related to the enhancment of antioxidant enzymes of GPx and SOD.
机译:以前,已经在体外研究了富硒绿茶提取物的抗氧化活性。在本研究中,体内微核试验被用来评估超细富硒绿茶粉(MSTP)在小鼠骨髓中的抗诱变作用。在环磷酰胺(CP)处理之前,连续连续29天对MSTP,微米级常规茶粉(MRTP),亚硒酸盐和MRTP +亚硒酸盐进行预处理。还研究了某些关键的抗氧化酶以阐明抗诱变作用的机制。结果表明,单独使用MSTP和MRTP或亚硒酸盐均不能显着诱导任何浓度的微核,从而证实了其非诱变性。在CP治疗组中,用MSTP,MRTP和亚硒酸盐预处理后,记录到微核的显着抑制。与阳性对照组相比,通过显着减少骨髓细胞中微核的频率,可以明显观察到MSTP的抗突变作用。 MSTP,亚硒酸盐和MRTP +亚硒酸盐的施用还增加了血液和肝脏中硒浓度,谷胱甘肽过氧化物酶(GPx)和超氧化物歧化酶(SOD)酶的水平。但是,在MSTP,亚硒酸盐和MRTP +亚硒酸盐之间,GPx和SOD的活性没有发现明显差异。目前的发现表明,MSTP的抗诱变潜力可能不仅与GPx和SOD的抗氧化酶的增强有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号